• Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of "Moderate Buy" by Brokerages

    Source: Buzz FX / 04 Mar 2025 01:52:12   America/Chicago


    Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc. ( NASDAQ:HALO - Get Free Report ) have
    Read more...
Share on,